Feature | April 21, 2015 | Jeff Zagoudis

U.S. Preventive Services Task Force Updates Breast Cancer Screening Recommendations

Guidelines place highest screening priority on women 50-74; recommendations could impact insurance coverage for women in their 40s

USPSTF, breast cancer, screening, recommendations

April 21, 2015 — The U.S. Preventive Services Task Force (USPSTF) has released a draft of its newest recommendations for breast cancer screening. These are available for public comment through May 18. 

The USPSTF offers mammography recommendations for women in three age brackets — ages 40-49, ages 50-74 and ages 75 and older — with an assigned letter grade based on priority. Women ages 50-74 received the highest priority with a “B” recommendation that they receive a screening mammography every two years.

According to the task force, women in their 40s should talk with their doctor and make their own decision on when to begin screening mammography. This age bracket received a “C” recommendation.

For the 75-and-older bracket, the USPSTF concluded that the current evidence was insufficient assess the relative benefits and risks of screening mammography. The evidence was also inconclusive for women with dense breasts.

Screening guidelines have proved to be a major source of controversy in recent years, as associations like the American College of Radiology (ACR) and Society of Breast Imaging (SBI) have strongly advocated for full coverage of mammograms beginning with women in their 40s.

The ACR and SBI released a joint statement on the latest recommendations, voicing concerns that women 40-49 would not be guaranteed insurance coverage for mammograms as a result of the lower-priority recommendation. The Affordable Care Act (ACA) requires private insurers to cover exams or procedures given a grade of “B” or higher by the USPSTF.

“The USPSTF limited its consideration to studies that underestimate the lifesaving benefit of regular screening and greatly inflate overdiagnosis claims. They ignored more modern studies that have shown much greater benefit. These limitations result in the misrepresentation of the real trade-offs that women and healthcare providers need to know about in order to make good decisions about screening. They also ignored the demonstrated views of American women on screening. Unfortunately, these recommendations will only add to confusion that is placing women at risk,” said Barbara Monsees, M.D., FACR, chair of the American College of Radiology Breast Imaging Commission.

A 2014 study in the American Journal of Roentgenology indicated that if USPSTF breast cancer screening guidelines were followed, approximately 6,500-10,000 additional women each year in the United States would die from breast cancer.

The costs associated with screening versus not screening have also factored in the debate, with screening advocates arguing that reducing screenings and coverage ignores the costs resulting from delayed diagnosis, including morbidity, lost income, treatment of metastatic disease and death.

For more information or to leave a comment on the draft recommendations:

www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/breast-cancer-screening1#Pod4

Related Content

Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Volpara Solutions to Showcase VolparaEnterprise Live! at RSNA
News | Mammography | October 16, 2017
Volpara Solutions will introduce VolparaEnterprise Live!, a mammography quality control tool, at the 2016 Radiological...
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas
News | Breast Imaging | October 04, 2017
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Kubtec Announces Expansion of 3-D Tomosynthesis Technology
News | Digital Radiography (DR) | October 04, 2017
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA
The Siemens Acuson

The Siemens Acuson

Feature | Breast Imaging | October 04, 2017 | By Melinda Taschetta-Millane
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent...
Overlay Init